Longbo Hu

806 total citations
27 papers, 591 citations indexed

About

Longbo Hu is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Longbo Hu has authored 27 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Immunology and 6 papers in Hepatology. Recurrent topics in Longbo Hu's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Longbo Hu is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Longbo Hu collaborates with scholars based in China and United States. Longbo Hu's co-authors include Tao Peng, Yipeng Qi, Guohua Yi, Lunguang Yao, Zhimin Wang, Leike Li, Wenxia Yao, Hua Cai, Feng Yang and Junzheng Wu and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Longbo Hu

27 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longbo Hu China 13 256 166 120 118 115 27 591
Kari A. Dilley United States 14 194 0.8× 358 2.2× 40 0.3× 86 0.7× 130 1.1× 14 630
Gaurav Shrivastava United States 12 267 1.0× 376 2.3× 51 0.4× 109 0.9× 226 2.0× 23 769
Jérémy Boussier France 12 247 1.0× 161 1.0× 67 0.6× 83 0.7× 163 1.4× 18 635
Thomas Thieme United States 13 96 0.4× 149 0.9× 44 0.4× 94 0.8× 20 0.2× 24 428
Anja Schröder Germany 11 293 1.1× 109 0.7× 14 0.1× 157 1.3× 79 0.7× 12 539
Sojan Abraham United States 13 213 0.8× 302 1.8× 26 0.2× 83 0.7× 115 1.0× 20 619
Weiqing Pan China 19 98 0.4× 278 1.7× 20 0.2× 87 0.7× 98 0.9× 33 902
Enjie Luo China 14 157 0.6× 171 1.0× 62 0.5× 54 0.5× 51 0.4× 38 535
Noriko Kubota Japan 13 97 0.4× 126 0.8× 22 0.2× 87 0.7× 37 0.3× 56 491
Patrícia R. Araújo Brazil 12 45 0.2× 265 1.6× 23 0.2× 183 1.6× 35 0.3× 24 521

Countries citing papers authored by Longbo Hu

Since Specialization
Citations

This map shows the geographic impact of Longbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbo Hu more than expected).

Fields of papers citing papers by Longbo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbo Hu. The network helps show where Longbo Hu may publish in the future.

Co-authorship network of co-authors of Longbo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Longbo Hu. A scholar is included among the top collaborators of Longbo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longbo Hu. Longbo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Longbo, et al.. (2023). A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus. Viruses. 15(7). 1548–1548. 4 indexed citations
2.
Hu, Longbo, Lu Zhang, Xiang Zhao, et al.. (2022). The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice. Viruses. 14(5). 854–854. 8 indexed citations
3.
Hu, Longbo, Mengdi Liang, Jinxian Huang, et al.. (2022). A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly. Antiviral Research. 209. 105509–105509. 4 indexed citations
4.
Hu, Longbo, et al.. (2022). The race toward a universal influenza vaccine: Front runners and the future directions. Antiviral Research. 210. 105505–105505. 17 indexed citations
5.
Xiao, Jing, Shaohua Lu, Xufei Wang, et al.. (2022). Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis. Frontiers in Immunology. 13. 866035–866035. 6 indexed citations
6.
Xiao, Jing, Longbo Hu, Long Tan, et al.. (2022). Advances in phosphoproteomics and its application to COPD. Expert Review of Proteomics. 19(7-12). 311–324. 2 indexed citations
7.
Du, Yingying, Feng Jin, Longbo Hu, et al.. (2021). Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse. Vaccine. 39(16). 2280–2287. 46 indexed citations
8.
Cai, Hua, Wenxia Yao, Jing Xiao, et al.. (2020). Apolipoprotein M, identified as a novel hepatitis C virus (HCV) particle associated protein, contributes to HCV assembly and interacts with E2 protein. Antiviral Research. 177. 104756–104756. 11 indexed citations
9.
Hu, Longbo, Hua Cai, Wenxia Yao, et al.. (2017). Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles. Antiviral Research. 148. 5–14. 13 indexed citations
10.
Cai, Hua, Wenxia Yao, Leike Li, et al.. (2016). Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A. Scientific Reports. 6(1). 27778–27778. 19 indexed citations
11.
Yao, Wanxia, et al.. (2015). Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation. Journal of Clinical Virology. 69. 228–228. 1 indexed citations
12.
Cai, Hua, et al.. (2015). Cell death-inducing DFFA-like effector B contributes to assembly of hepatitis C virus (HCV) particles and interacts with HCV NS5A. Journal of Clinical Virology. 69. 228–229. 1 indexed citations
13.
Wang, Fang, Qi Long, Yu Gong, et al.. (2014). Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells. Cell & Bioscience. 4(1). 76–76. 14 indexed citations
14.
Hu, Longbo, Wenxia Yao, Fang Wang, Rong Xia, & Tao Peng. (2014). GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion. PLoS ONE. 9(3). e90553–e90553. 22 indexed citations
15.
Wang, Fang, Leike Li, Longbo Hu, et al.. (2014). GP73 was upregulated in PBMC stimulated with ConA but failed to promote lymphocyte proliferation. Cell Biology International. 39(3). 334–340. 2 indexed citations
16.
Hu, Longbo, Leike Li, Hong‐Bin Xie, Yanli Gu, & Tao Peng. (2011). The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences. PLoS ONE. 6(11). e28207–e28207. 46 indexed citations
17.
Zhou, Yan, Leike Li, Longbo Hu, & Tao Peng. (2010). Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin. Molecular Biology Reports. 38(3). 1457–1462. 36 indexed citations
18.
Li, Xiao, Rong Zhou, Longbo Hu, et al.. (2007). [Cloning, expression and immunocharacterization of the capsid protein of human Norwalk virus Guangzhou strain NVgz01].. PubMed. 27(9). 1410–3. 1 indexed citations
19.
Yi, Guohua, et al.. (2004). Vp28 of Shrimp White Spot Syndrome Virus Is Involved in the Attachment and Penetration into Shrimp Cells. BMB Reports. 37(6). 726–734. 165 indexed citations
20.
Wang, Zhimin, et al.. (2004). ORF390 of white spot syndrome virus genome is identified as a novel anti-apoptosis gene. Biochemical and Biophysical Research Communications. 325(3). 899–907. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kari A. Dilley Breakdown of academic impact, for papers by Gaurav Shrivastava Breakdown of academic impact, for papers by Jérémy Boussier Breakdown of academic impact, for papers by Thomas Thieme Breakdown of academic impact, for papers by Anja Schröder Breakdown of academic impact, for papers by Sojan Abraham Breakdown of academic impact, for papers by Weiqing Pan Breakdown of academic impact, for papers by Enjie Luo Breakdown of academic impact, for papers by Noriko Kubota Breakdown of academic impact, for papers by Patrícia R. Araújo
Rankless by CCL
2026